Cargando…

Characterisation of individual ferritin response in patients receiving chelation therapy

AIMS: To develop a drug–disease model describing iron overload and its effect on ferritin response in patients affected by transfusion‐dependent haemoglobinopathies and investigate the contribution of interindividual differences in demographic and clinical factors on chelation therapy with deferipro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borella, Elisa, Oosterholt, Sean, Magni, Paolo, Della Pasqua, Oscar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544664/ https://www.ncbi.nlm.nih.gov/pubmed/35199367 http://dx.doi.org/10.1111/bcp.15290

Ejemplares similares

Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate–Severe Symptoms
por: Singh, Dave, et al.
Publicado: (2023)

Model-Based Optimisation of Deferoxamine Chelation Therapy
por: Bellanti, Francesco, et al.
Publicado: (2015)

5613464 INTEGRATION OF PHARMACOKINETIC AND PHARMACODYNAMIC MODELS TO MULTI-CRITERIA DECISION ANALYSIS (MCDA) FOR PROSPECTIVE ASSESSMENT OF THE RISK-BENEFIT RATIO OF ORAL IRON CHELATORS IN PAEDIATRIC PATIENTS WITH TRANSFUSION-DEPENDENT HAEMOGLOBINOPATHIES
por: Della Pasqua, O.D.P., et al.
Publicado: (2023)

Characterisation of Ferritin–Lymphocyte Ratio in COVID-19
por: Liu, Alexander, et al.
Publicado: (2023)

Clinical view versus guideline adherence in ferritin monitoring and initiating iron chelation therapy in patients with myelodysplastic syndromes
por: Rozema, Johanne, et al.
Publicado: (2022)

Cloning and Characterisation of Multiple Ferritin Isoforms in the Atlantic Salmon (Salmo salar)
por: Lee, Jun-Hoe, et al.
Publicado: (2014)

Characterising body composition and bone health in transgender individuals receiving gender‐affirming hormone therapy
por: Ford, Ky, et al.
Publicado: (2022)

Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome
por: Glaze, Daniel G., et al.
Publicado: (2019)

Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009)

The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML: A meta-analysis
por: Yang, Yuan, et al.
Publicado: (2019)

Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®)
por: Vini, Dimitra, et al.
Publicado: (2011)

Model‐based prediction of effective target exposure for MEN1611 in combination with trastuzumab in HER2‐positive advanced or metastatic breast cancer patients
por: Tosca, Elena M., et al.
Publicado: (2023)

Cardiac sodium channel inhibition by lamotrigine: In vitro characterization and clinical implications
por: Ingleby‐Talecki, Lindsey, et al.
Publicado: (2022)

Effect of supplementation with ferrous sulfate or iron bis-glycinate chelate on ferritin concentration in Mexican schoolchildren: a randomized controlled trial
por: Duque, Ximena, et al.
Publicado: (2014)

Chelation therapy after the Trial to Assess Chelation Therapy: results of a unique trial
por: Avila, Maria D., et al.
Publicado: (2014)

Ferritin in glioblastoma
por: Jaksch-Bogensperger, Heidi, et al.
Publicado: (2020)

Markers of Renal Complications in Beta Thalassemia Patients with Iron Overload Receiving Chelation Agent Therapy: A Systematic Review
por: Romadhon, Pradana Zaky, et al.
Publicado: (2022)

Complex Bayesian Modeling Workflows Encoding and Execution Made Easy With a Novel WinBUGS Plugin of the Drug Disease Model Resources Interoperability Framework
por: Larizza, Cristiana, et al.
Publicado: (2018)

Ferritin-bearing T-lymphocytes and serum ferritin in patients with breast cancer.
por: Pattanapanyasat, K., et al.
Publicado: (1988)

Chelation therapy in liver diseases of childhood: Current status and response
por: Seetharaman, Jayendra, et al.
Publicado: (2021)

Serum ferritin levels and irregular use of iron chelators predict liver iron load in patients with major beta thalassemia: a cross-sectional study
por: Sobhani, Soheila, et al.
Publicado: (2019)

Bioengineered Ferritin Nanocarriers for Cancer Therapy
por: Sun, Xuanrong, et al.
Publicado: (2021)

Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade®, ICL670)
por: Di Tucci, Anna Angela, et al.
Publicado: (2007)

Quality of life, clinical effectiveness, and satisfaction in patients with beta thalassemia major and sickle cell anemia receiving deferasirox chelation therapy
por: Senol, Sefika Pinar, et al.
Publicado: (2016)

Estimation of Serum Ferritin in Mucormycosis Patients and Prognostication Based on the Ferritin Value
por: Anand C, Babu, et al.
Publicado: (2022)

Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition
por: Cuffaro, Doretta, et al.
Publicado: (2022)

Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

EDTA Chelation Therapy for the Treatment of Neurotoxicity
por: Fulgenzi, Alessandro, et al.
Publicado: (2019)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

Lead toxicosis of captive vultures: case description and responses to chelation therapy
por: Pikula, Jiri, et al.
Publicado: (2013)

5613341 REAL-WORLD CHANGES IN KIDNEY FUNCTION FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANAEMIAS RECEIVING IRON CHELATION THERAPY IN THE US
por: Sunil Bhandari, S.B., et al.
Publicado: (2023)

Circulating ferritin concentrations and risk of type 2 diabetes in Japanese individuals
por: Akter, Shamima, et al.
Publicado: (2017)

Advances on Chelation and Chelator Metal Complexes in Medicine †
por: Kontoghiorghes, George J.
Publicado: (2020)

Prospective changes of pancreatic iron in patients with thalassemia major and association with chelation therapy
por: Meloni, Antonella, et al.
Publicado: (2022)

Changes in inflammatory cytokines, antioxidants and liver stiffness after chelation therapy in individuals with chronic lead poisoning
por: Teerasarntipan, Tongluk, et al.
Publicado: (2020)

Who Receives Medicaid in Old Age? Rules and Reality
por: Borella, Margherita, et al.
Publicado: (2017)

Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review
por: Ravalli, Filippo, et al.
Publicado: (2022)

Prospective changes of cardiac iron and function by MR in pediatric thalassemia major patients treated with different chelators or not chelated
por: Meloni, Antonella, et al.
Publicado: (2015)

Current Biomedical Use of Copper Chelation Therapy
por: Baldari, Silvia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4cqm0l2dekds2of480be9s4j3s